Robert N. Proctor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert N. Proctor has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Gary S. Cross
1 shared publication- Ruth E. Malone
Social and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA
1 shared publication Susan Lee Pentlin
1 shared publicationTerrell Stevenson
School of Medicine, University of California, San Francisco, CA, USA
1 shared publicationUniversity of Miami / Georgia Tech
1 shared publication
Latest Publications
- 1 November 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (11) , 1143-1145
The Making of the 1964 Surgeon General’s Report on Smoking and Health
- 1 November 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (11) , 1143-1145
The Making of the 1964 Surgeon General’s Report on Smoking and Health
- Open Access
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 376-381
Prohibition no, abolition yes! Rethinking how we talk about ending the cigarette epidemic
As public health advocates struggle over how best to end the cigarette epidemic, one persistent obstacle to developing appropriate policies has been the lingering spectre of ‘prohibition’. A misunderstanding of the USA’s experience with the national ban on sales of alcohol more than a century ago has led even public health advocates to claim that we cannot end the sale of cigarettes because ‘prohibition does not work’: a ban on sales, we hear, would lead to crime and to black markets, among many other negatives. In this Special Communication, we show how the tobacco industry has carefully constructed and reinforced this imagined impossibility, creating a false analogy between cigarettes and alcohol. This improper analogy, with its multiple negative associations, continues to block intelligent thinking about how to end cigarette sales. Instead of prohibition, we propose abolition as a term that better captures what ending sales of the single most deadly consumer product in history will actually do: enhance human health and freedom.
- 3 March 2022
- Published by BMJ in Tobacco Control
- Vol. 31 (2) , 376-381
Open AccessProhibition no, abolition yes! Rethinking how we talk about ending the cigarette epidemic
As public health advocates struggle over how best to end the cigarette epidemic, one persistent obstacle to developing appropriate policies has been the lingering spectre of ‘prohibition’. A misunderstanding of the USA’s experience with the national ban on sales of alcohol more than a century ago has led even public health advocates to claim that we cannot end the sale of cigarettes because ‘prohibition does not work’: a ban on sales, we hear, would lead to crime and to black markets, among many other negatives. In this Special Communication, we show how the tobacco industry has carefully constructed and reinforced this imagined impossibility, creating a false analogy between cigarettes and alcohol. This improper analogy, with its multiple negative associations, continues to block intelligent thinking about how to end cigarette sales. Instead of prohibition, we propose abolition as a term that better captures what ending sales of the single most deadly consumer product in history will actually do: enhance human health and freedom.
- Open Access
- 15 January 2018
- Published by Springer Nature in Journal of Public Health Policy
- Vol. 39 (1) , 24-26
God is watching: history in the age of near-infinite digital archives
- 15 January 2018
- Published by Springer Nature in Journal of Public Health Policy
- Vol. 39 (1) , 24-26
Open AccessGod is watching: history in the age of near-infinite digital archives
- 1 March 2015
- Published by Elsevier in The Lancet
- Vol. 385 (9972) , 938-939
The cigarette catastrophe continues
- 1 March 2015
- Published by Elsevier in The Lancet
- Vol. 385 (9972) , 938-939
The cigarette catastrophe continues
- Top Cited PapersOpen Access
- 15 April 2013
- Published by BMJ in Tobacco Control
- Vol. 22 (suppl 1) , i27-i30
Why ban the sale of cigarettes? The case for abolition
The cigarette is the deadliest artefact in the history of human civilisation. Most of the richer countries of the globe, however, are making progress in reducing both smoking rates and overall consumption. Many different methods have been proposed to steepen this downward slope, including increased taxation, bans on advertising, promotion of cessation, and expansion of smoke-free spaces. One option that deserves more attention is the enactment of local or national bans on the sale of cigarettes. There are precedents: 15 US states enacted bans on the sale of cigarettes from 1890 to 1927, for instance, and such laws are still fully within the power of local communities and state governments. Apart from reducing human suffering, abolishing the sale of cigarettes would result in savings in the realm of healthcare costs, increased labour productivity, lessened harms from fires, reduced consumption of scarce physical resources, and a smaller global carbon footprint. Abolition would also put a halt to one of the principal sources of corruption in modern civilisation, and would effectively eliminate one of the historical forces behind global warming denial and environmental obfuscation. The primary reason for abolition, however, is that smokers themselves dislike the fact they smoke. Smoking is not a recreational drug, and abolishing cigarettes would therefore enlarge rather than restrict human liberties. Abolition would also help cigarette makers fulfil their repeated promises to ‘cease production’ if cigarettes were ever found to be causing harm.
- 15 April 2013
- Published by BMJ in Tobacco Control
- Vol. 22 (suppl 1) , i27-i30
Top Cited PapersOpen AccessWhy ban the sale of cigarettes? The case for abolition
The cigarette is the deadliest artefact in the history of human civilisation. Most of the richer countries of the globe, however, are making progress in reducing both smoking rates and overall consumption. Many different methods have been proposed to steepen this downward slope, including increased taxation, bans on advertising, promotion of cessation, and expansion of smoke-free spaces. One option that deserves more attention is the enactment of local or national bans on the sale of cigarettes. There are precedents: 15 US states enacted bans on the sale of cigarettes from 1890 to 1927, for instance, and such laws are still fully within the power of local communities and state governments. Apart from reducing human suffering, abolishing the sale of cigarettes would result in savings in the realm of healthcare costs, increased labour productivity, lessened harms from fires, reduced consumption of scarce physical resources, and a smaller global carbon footprint. Abolition would also put a halt to one of the principal sources of corruption in modern civilisation, and would effectively eliminate one of the historical forces behind global warming denial and environmental obfuscation. The primary reason for abolition, however, is that smokers themselves dislike the fact they smoke. Smoking is not a recreational drug, and abolishing cigarettes would therefore enlarge rather than restrict human liberties. Abolition would also help cigarette makers fulfil their repeated promises to ‘cease production’ if cigarettes were ever found to be causing harm.
- Top Cited Papers
- 16 February 2012
- Published by BMJ in Tobacco Control
- Vol. 21 (2) , 87-91
The history of the discovery of the cigarette–lung cancer link: evidentiary traditions, corporate denial, global toll: Table 1
Lung cancer was once a very rare disease, so rare that doctors took special notice when confronted with a case, thinking it a once-in-a-lifetime oddity. Mechanisation and mass marketing towards the end of the 19th century popularised the cigarette habit, however, causing a global lung cancer epidemic. Cigarettes were recognised as the cause of the epidemic in the 1940s and 1950s, with the confluence of studies from epidemiology, animal experiments, cellular pathology and chemical analytics. Cigarette manufacturers disputed this evidence, as part of an orchestrated conspiracy to salvage cigarette sales. Propagandising the public proved successful, judging from secret tobacco industry measurements of the impact of denialist propaganda. As late as 1960 only one-third of all US doctors believed that the case against cigarettes had been established. The cigarette is the deadliest artefact in the history of human civilisation. Cigarettes cause about 1 lung cancer death per 3 or 4 million smoked, which explains why the scale of the epidemic is so large today. Cigarettes cause about 1.5 million deaths from lung cancer per year, a number that will rise to nearly 2 million per year by the 2020s or 2030s, even if consumption rates decline in the interim. Part of the ease of cigarette manufacturing stems from the ubiquity of high-speed cigarette making machines, which crank out 20 000 cigarettes per min. Cigarette makers make about a penny in profit for every cigarette sold, which means that the value of a life to a cigarette maker is about US$10 000.
- 16 February 2012
- Published by BMJ in Tobacco Control
- Vol. 21 (2) , 87-91
Top Cited PapersThe history of the discovery of the cigarette–lung cancer link: evidentiary traditions, corporate denial, global toll: Table 1
Lung cancer was once a very rare disease, so rare that doctors took special notice when confronted with a case, thinking it a once-in-a-lifetime oddity. Mechanisation and mass marketing towards the end of the 19th century popularised the cigarette habit, however, causing a global lung cancer epidemic. Cigarettes were recognised as the cause of the epidemic in the 1940s and 1950s, with the confluence of studies from epidemiology, animal experiments, cellular pathology and chemical analytics. Cigarette manufacturers disputed this evidence, as part of an orchestrated conspiracy to salvage cigarette sales. Propagandising the public proved successful, judging from secret tobacco industry measurements of the impact of denialist propaganda. As late as 1960 only one-third of all US doctors believed that the case against cigarettes had been established. The cigarette is the deadliest artefact in the history of human civilisation. Cigarettes cause about 1 lung cancer death per 3 or 4 million smoked, which explains why the scale of the epidemic is so large today. Cigarettes cause about 1.5 million deaths from lung cancer per year, a number that will rise to nearly 2 million per year by the 2020s or 2030s, even if consumption rates decline in the interim. Part of the ease of cigarette manufacturing stems from the ubiquity of high-speed cigarette making machines, which crank out 20 000 cigarettes per min. Cigarette makers make about a penny in profit for every cigarette sold, which means that the value of a life to a cigarette maker is about US$10 000.
- 1 July 2008
- Published by American Public Health Association in American Journal of Public Health
- Vol. 98 (7) , 1184-1194
The SECRET and SOUL of Marlboro
Philip Morris and other tobacco companies have been using ammonia in their manufacturing for more than half a century, and for a variety of purposes: to highlight certain flavors, to expand or “puff up” the volume of tobacco, to prepare reconstituted tobacco sheet (“recon”), to denicotinize (reduce the amount of nicotine in) tobacco, and to remove carcinogens. By the early 1960s, however, Philip Morris had also begun using ammonia to “freebase” the nicotine in cigarette smoke, creating low-yield (reduced-tar or -nicotine) cigarettes that still had the nicotine kick necessary to keep customers “satisfied” (i.e., addicted). We show that Philip Morris discovered the virtues of freebasing while analyzing the impact of the ammoniated recon used in Marlboro cigarettes. We also show how Marlboro’s commercial success catalyzed efforts by the rest of the tobacco industry to discover its “secret,” eventually identified as ammonia technology, and how Philip Morris later exploited the myriad uses of ammonia (e.g., for flavoring and expanding tobacco volume) to defend itself against charges of manipulating the nicotine deliveries of its cigarettes.
- 1 July 2008
- Published by American Public Health Association in American Journal of Public Health
- Vol. 98 (7) , 1184-1194
The SECRET and SOUL of Marlboro
Philip Morris and other tobacco companies have been using ammonia in their manufacturing for more than half a century, and for a variety of purposes: to highlight certain flavors, to expand or “puff up” the volume of tobacco, to prepare reconstituted tobacco sheet (“recon”), to denicotinize (reduce the amount of nicotine in) tobacco, and to remove carcinogens. By the early 1960s, however, Philip Morris had also begun using ammonia to “freebase” the nicotine in cigarette smoke, creating low-yield (reduced-tar or -nicotine) cigarettes that still had the nicotine kick necessary to keep customers “satisfied” (i.e., addicted). We show that Philip Morris discovered the virtues of freebasing while analyzing the impact of the ammoniated recon used in Marlboro cigarettes. We also show how Marlboro’s commercial success catalyzed efforts by the rest of the tobacco industry to discover its “secret,” eventually identified as ammonia technology, and how Philip Morris later exploited the myriad uses of ammonia (e.g., for flavoring and expanding tobacco volume) to defend itself against charges of manipulating the nicotine deliveries of its cigarettes.
- 4 May 2007
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 316 (5825) , 692-693
The Golden Weed, America's Most Deadly Drug
The Cigarette Century. The Rise, Fall, and Deadly Persistence of the Product That Defined America.By Allan M. Brandt. Basic Books, New York, 2007. 640 pp. $36, C$43.50. ISBN 9780465070473.In this history of changing attitudes toward smoking, Brandt describes how the tobacco industry promoted "the most deadly addiction on the planet."
- 4 May 2007
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 316 (5825) , 692-693
The Golden Weed, America's Most Deadly Drug
The Cigarette Century. The Rise, Fall, and Deadly Persistence of the Product That Defined America.By Allan M. Brandt. Basic Books, New York, 2007. 640 pp. $36, C$43.50. ISBN 9780465070473.In this history of changing attitudes toward smoking, Brandt describes how the tobacco industry promoted "the most deadly addiction on the planet."
- 27 November 2006
- Published by BMJ in Tobacco Control
- Vol. 15 (suppl 4) , iv117-iv125
“Everyone knew but no one had proof”: tobacco industry use of medical history expertise in US courts, 1990–2002
Historians have played an important role in recent tobacco litigation, helping the industry with its defence of “common knowledge” and “open controversy”. Historians re-narrate the past, creating an account for judges and juries that makes it appear that “everyone has always known” that cigarettes are harmful, meaning that smokers have only themselves to blame for their illnesses. Medical historians are also employed to argue that “honest doubts” persisted in the medical community long past the 1950s, justifying as responsible the industry’s longstanding claim of “no proof” of hazards. The industry’s experts emphasise the “good science” supported by the industry, and ignore the industry’s role in spreading doubts about the reality of tobacco hazards.
- 27 November 2006
- Published by BMJ in Tobacco Control
- Vol. 15 (suppl 4) , iv117-iv125
“Everyone knew but no one had proof”: tobacco industry use of medical history expertise in US courts, 1990–2002
Historians have played an important role in recent tobacco litigation, helping the industry with its defence of “common knowledge” and “open controversy”. Historians re-narrate the past, creating an account for judges and juries that makes it appear that “everyone has always known” that cigarettes are harmful, meaning that smokers have only themselves to blame for their illnesses. Medical historians are also employed to argue that “honest doubts” persisted in the medical community long past the 1950s, justifying as responsible the industry’s longstanding claim of “no proof” of hazards. The industry’s experts emphasise the “good science” supported by the industry, and ignore the industry’s role in spreading doubts about the reality of tobacco hazards.